Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patients with myelofibrosis: updated data
2018
9th International Eurasian Hematology Oncology Congress (EHOC) - OCT 17-20, 2018 - Istanbul, TURKEY
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI